[1] Nazir MA. Prevalence of periodontal disease, its association with systemic diseases and prevention. International journal of health sciences. 2017;11(2):72-80.
[2] Nascimento GG, Alves‐Costa S, Romandini M. Burden of severe periodontitis and edentulism in 2021, with projections up to 2050: The Global Burden of Disease 2021 study. Journal of Periodontal Research. 2024;59(5):823-67. https://doi.org/10.1111/jre.13337.
[3] Scannapieco FA, Dongari‐Bagtzoglou A. Dysbiosis revisited: Understanding the role of the oral microbiome in the pathogenesis of gingivitis and periodontitis: A critical assessment. Journal of periodontology. 2021;92(8):1071-8. https://doi.org/10.1002/JPER.21-0120.
[4] Usui M, Onizuka S, Sato T, Kokabu S, Ariyoshi W, Nakashima K. Mechanism of alveolar bone destruction in periodontitis—Periodontal bacteria and inflammation. Japanese Dental Science Review. 2021;57:201-8. https://doi.org/10.1016/j.jdsr.2021.09.005.
[5] Van Dyke TE. The management of inflammation in periodontal disease. Journal of periodontology. 2008;79:1601-8. https://doi.org/10.1902/jop.2008.080173.
[6] Cortellini P, Tonetti MS. Clinical concepts for regenerative therapy in intrabony defects. Periodontology 2000. 2015;68(1):282-307. https://doi.org/10.1111/prd.12048.
[7] Schmidt AH. Autologous bone graft: Is it still the gold standard?. Injury. 2021;52:S18-22. https://doi.org/10.1016/j.injury.2021.01.043.
[8] Sohn HS, Oh JK. Review of bone graft and bone substitutes with an emphasis on fracture surgeries. Biomaterials research. 2019;23(1):9. https://doi.org/10.1186/s40824-019-0157-y.
[9] Toledano-Serrabona J, Ruiz-Romero V, Camps-Font O, Gay-Escoda C, Sánchez-Garcés MÁ. A systematic review and meta-analysis on the effectiveness of xenograft to prevent periodontal defects after mandibular third molar extraction. Medicina Oral, Patologia Oral y Cirugia Bucal. 2020;26(4):e414. https://doi.org/10.4317/medoral.24260.
[10] Miron RJ, Shirakata Y, Ahmad P, Romandini M, Estrin NE, Farshidfar N, et al. 30 years of enamel matrix derivative: Mimicking tooth development as a clinical concept. Periodontology 2000. https://doi.org/10.1111/prd.12635.
[11] Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 2006;101(3):e37-44. https://doi.org/10.1016/j.tripleo.2005.07.008.
[12] Miron RJ, Moraschini V, Estrin NE, Shibli JA, Cosgarea R, Jepsen K, et al. Periodontal Regeneration using Platelet‐Rich Fibrin. Furcation defects: a systematic review with meta‐analysis. Periodontology 2000. 2025;97(1):191-214. https://doi.org/10.1111/prd.12583.
[13] Silva FF, Chauca-Bajaña L, Caponio VC, Cueva KA, Velasquez-Ron B, Padín-Iruegas ME, et al. Regeneration of periodontal intrabony defects using platelet-rich fibrin (PRF): a systematic review and network meta-analysis. Odontology. 2024;112(4):1047-68. https://doi.org/10.1007/s10266-024-00949-7.
[14] Choukroun J, Ghanaati RS. Reduction of relative centrifugation force within injectable platelet-rich-fibrin (PRF) concentrates advances patients’ own inflammatory cells, platelets and growth factors: the first introduction to the low speed centrifugation concept. European journal of trauma and emergency surgery. 2018;44(1):87-95. https://doi.org/10.1007/s00068-017-0767-9.
[15] Miron RJ, Gruber R, Farshidfar N, Sculean A, Zhang Y. Ten years of injectable platelet‐rich fibrin. Periodontology 2000. 2024;94(1):92-113. https://doi.org/10.1111/prd.12538.
[16] Miron RJ, Fujioka-Kobayashi M, Hernandez M, Kandalam U, Zhang Y, Ghanaati S, et al. Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry?. Clinical oral investigations. 2017;21(8):2619-27. https://doi.org/10.1007/s00784-017-2063-9.
[17] Sareen V, Santhi K, Saxena I, Selvaraj U, Vijayabharathi P, Chauhan S, et al. Role of sticky bone in the management of various alveolar bone defects: a systematic review. Cureus. 2024;16(7):e63561. https://doi.org/10.7759/cureus.63561.
[18] Kobayashi E, Flückiger L, Fujioka-Kobayashi M, Sawada K, Sculean A, Schaller B, et al. Comparative release of growth factors from PRP, PRF, and advanced-PRF. Clinical oral investigations. 2016;20(9):2353-60. https://doi.org/10.1007/s00784-016-1719-1.
[19] Sohn DS, Huang B, Kim J, Park WE, Park CC. Utilization of autologous concentrated growth factors (CGF) enriched bone graft matrix (sticky bone) and CGF-enriched fibrin membrane in implant dentistry. J Implant Adv Clin Dent. 2015;7(10):11-8.
[20] Thanasrisuebwong P, Kiattavorncharoen S, Surarit R, Phruksaniyom C, Ruangsawasdi N. Red and yellow injectable platelet-rich fibrin demonstrated differential effects on periodontal ligament stem cell proliferation, migration, and osteogenic differentiation. International journal of molecular sciences. 2020;21(14):5153. https://doi.org/10.3390/ijms21145153.
[21] Dohle E, El Bagdadi K, Sader R, Choukroun J, James Kirkpatrick C, Ghanaati S. Platelet‐rich fibrin‐based matrices to improve angiogenesis in an in vitro co‐culture model for bone tissue engineering. Journal of tissue engineering and regenerative medicine. 2018;12(3):598-610. https://doi.org/10.1002/term.2475.
[22] Strauss FJ, Nasirzade J, Kargarpoor Z, Stähli A, Gruber R. Effect of platelet-rich fibrin on cell proliferation, migration, differentiation, inflammation, and osteoclastogenesis: a systematic review of in vitro studies. Clinical oral investigations. 2020;24(2):569-84. https://doi.org/10.1007/s00784-019-03156-9.
[23] Nasirzade J, Kargarpour Z, Hasannia S, Strauss FJ, Gruber R. Platelet‐rich fibrin elicits an anti‐inflammatory response in macrophages in vitro. Journal of periodontology. 2020;91(2):244-52. https://doi.org/10.1002/JPER.19-0216.
[24] Wang X, Zhang Y, Choukroun J, Ghanaati S, Miron RJ. Effects of an injectable platelet-rich fibrin on osteoblast behavior and bone tissue formation in comparison to platelet-rich plasma. Platelets. 2018;29(1):48-55. https://doi.org/10.1080/09537104.2017.1293807.
[25] Sumida R, Maeda T, Kawahara I, Yusa J, Kato Y. Platelet-rich fibrin increases the osteoprotegerin/receptor activator of nuclear factor-κB ligand ratio in osteoblasts. Experimental and Therapeutic Medicine. 2019;18(1):358-65. https://doi.org/10.3892/etm.2019.7560.
[26] Kour P, Pudakalkatti PS, Vas AM, Das S, Padmanabhan S. Comparative evaluation of antimicrobial efficacy of platelet-rich plasma, platelet-rich fibrin, and injectable platelet-rich fibrin on the standard strains of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans. Contemporary clinical dentistry. 2018;9(Suppl 2):S325-30. https://doi.org/10.4103/ccd.ccd_367_18.
[27] Kyyak S, Blatt S, Schiegnitz E, Heimes D, Staedt H, Thiem DG, et al. Activation of human osteoblasts via different bovine bone substitute materials with and without injectable platelet rich fibrin in vitro. Frontiers in bioengineering and biotechnology. 2021;9:599224. https://doi.org/10.3389/fbioe.2021.599224.
[28] Rupawala TA, Patel SM, Shah NH, Sanghvi KB, Makwana SV, Bhimani KK. Efficacy of sticky bone as a novel autologous graft for mandibular third molar extraction socket healing-An evaluative study. Annals of maxillofacial surgery. 2020;10(2):335-43. https://doi.org/10.4103/ams.ams_40_20.
[29] Salama MH, Bilal AM, Hosny MM, Abozaid HM, Hashem AH, Borhamy AL, et al. Efficacy of Sticky Bone with Repeated Injectable Platelet-rich Fibrin Application in the Management of Periodontal Intrabony Defects: Randomized Controlled Clinical Trial. The Open Dentistry Journal. 2025;19(1).
[30] Ghoderao D, Rathod S, Kolte AP, Bawankar P, Jadhav A. Randomized, controlled clinical trial to evaluate efficacy of sticky bone and concentrated growth factor in the management of intrabony defects: 12 months follow-up study. Dental Research Journal. 2022;19(1):67. https://doi.org/10.4103/1735-3327.353836.
